Skip to main content

Advertisement

SpringerLink
Log in

Intraventricular Nicardipine for Aneurysmal Subarachnoid Hemorrhage Related Vasospasm: Assessment of 90 Days Outcome

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Delayed cerebral arterial vasospasm is one of the leading causes of death and disability after aneurysmal subarachnoid hemorrhage (aSAH). We evaluated the safety of intraventricular nicardipine (IVN) for vasospasm (VSP) in aSAH patients, and outcomes compared with a control population.

Methods

A retrospective case–control study was conducted for aSAH patients treated with IVN at Mayo Clinic, Jacksonville, FL, from March 2009 to January 2011. Controls were matched by age, gender, and Fisher grade. Safety was evaluated by the incidence of intracranial bleeding and infection. Outcome was measured by Glasgow Outcome Scale at 30 and 90 days. IVN effects on VSP were evaluated by transcranial Doppler (TCD).

Results

Thirteen aSAH patients and one arteriovenous malformation (AVM)-related SAH patient received IVN for VSP and were matched with 14 aSAH patients without IVN therapy for a total of 28 cases. Median dose was 4 mg (range 3–7), and median number of doses was seven (range 1–17). Mean flow velocity decreased after IVN (120.2 and 101.6 cm/s–82.0 and 72.8 cm/s, right and left middle cerebral arteries, respectively). No significant difference was seen in clinical outcomes between controls and cases at 30 days (P = 0.443) and 90 days (P = 0.153). There were no incidences of bleeding or infection with 111 nicardipine injections.

Conclusions

IVN appears relatively safe and effective in treating VSP by TCD, but there was no difference in clinical outcomes between nicardipine and control patients at 30 and 90 days. In the future, larger studies are needed to evaluate the clinical outcome with IVN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Edlow JA, Malek AM, Ogilvy CS. Aneurysmal subarachnoid hemorrhage: update for emergency physicians. J Emerg Med. 2008;34:237–51.

    Article  PubMed  Google Scholar 

  2. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315–28.

    Article  PubMed  CAS  Google Scholar 

  3. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.

    Article  PubMed  Google Scholar 

  4. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48:249–61. discussion 61–62.

    PubMed  CAS  Google Scholar 

  5. Goodson K, Lapointe M, Monroe T, Chalela JA. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2008;8:247–52.

    Article  PubMed  CAS  Google Scholar 

  6. Webb A, Kolenda J, Martin K, Wright W, Samuels O. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;12:159–64.

    Article  PubMed  CAS  Google Scholar 

  7. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128–33.

    Article  PubMed  Google Scholar 

  8. Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, Tomassoni D. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. J Neurol Sci. 2009;283:219–23.

    Article  PubMed  Google Scholar 

  9. Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg. 1993;78:537–47.

    Article  PubMed  Google Scholar 

  10. Barth M, Thome C, Schmiedek P, Weiss C, Kasuya H, Vajkoczy P. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants. J Neurosurg. 2009;110:955–60.

    Article  PubMed  Google Scholar 

  11. Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J. 2009;102:150–3.

    Article  PubMed  Google Scholar 

  12. Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit care. 2011;15:400–4.

    Article  PubMed  Google Scholar 

  13. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002;33:1011–5.

    Article  PubMed  CAS  Google Scholar 

  14. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke. 2007;38:330–6.

    Article  PubMed  CAS  Google Scholar 

  15. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.

    Article  PubMed  CAS  Google Scholar 

  16. CONSCIOUS-3 Clinical Trial. Internet Stroke Center.org. 2011. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=1013. Accessed Aug, 2011.

  17. Washington CW, Zipfel GJ. Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit care. 2011;15:312–7.

    Article  PubMed  Google Scholar 

  18. Cerebrovascular ultrasound in stroke prevention and treatment. Elmsford: Blackwell Publishing; 2004. p 161–169.

  19. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101:1–7.

    Article  PubMed  Google Scholar 

  20. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10:157–65.

    Article  PubMed  CAS  Google Scholar 

  21. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499–507.

    Article  PubMed  Google Scholar 

  22. Tseng MY, Hutchinson PJ, Kirkpatrick PJ. Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study. Br J Neurosurg. 2008;22:257–68.

    Article  PubMed  Google Scholar 

  23. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006;59:775–9. discussion 9-80.

    Article  PubMed  Google Scholar 

  24. Kramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey. Crit Care. 2011;15:R30.

    Article  PubMed  Google Scholar 

Download references

Disclosures

No conflicts of interest or pertinent financial disclosures. The data will be presented in part at the Neurocritical Care Society meeting in abstract form September 21, 2011, in Montreal.

Author information

Authors and Affiliations

  1. Clinical Research Internship Study Program (CRISP), Mayo Clinic, Jacksonville, FL, USA

    Na Lu

  2. Department of Pharmacy, Mayo Clinic, Jacksonville, FL, USA

    Daniel Jackson

  3. Department of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA

    Sothear Luke & William David Freeman

  4. Department of Critical Care, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA

    Emir Festic & William David Freeman

  5. Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA

    Ricardo A. Hanel

Authors
  1. Na Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sothear Luke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emir Festic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ricardo A. Hanel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William David Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William David Freeman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, N., Jackson, D., Luke, S. et al. Intraventricular Nicardipine for Aneurysmal Subarachnoid Hemorrhage Related Vasospasm: Assessment of 90 Days Outcome. Neurocrit Care 16, 368–375 (2012). https://doi.org/10.1007/s12028-011-9659-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-011-9659-8

Keywords

Search

Navigation